← Leaderboards
Zeina Jaffar
University Of Montana
$1,016,722
Attributed
$1,016,722
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $431.2K · FY2009–18$500K$375K$250K$125K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$1,016,722 · 4
By mechanism
R15$841,117 · 2
P20$175,605 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Montana
Same institution · by research overlap
- Anthony John Ward$11,735,510
- Curtis William Noonan$13,652,734
- Christopher Todd Migliaccio$1,734,731
- Annie Elise Belcourt$872,112
- Erin O'Brien Semmens$1,692,104
Others in their field
Top investigators on “Source”
- Richard A Gibbs · Baylor College Of Medicine$285,393,445
- David Heimbrook · Leidos Biomedical Research, Inc.$233,184,481
- Robert B Gagosian · Consortium For Ocean Leadership, Inc$232,495,072
- Jeffrey P Krischer · University Of South Florida$224,745,020
- Albert Lazzarini · California Institute Of Technology$202,317,285
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$155,571,437
Research focus
SourceLung InflammationAllergicResponseAllergic Airway InflammationGrantLungCellsPlayExtrinsic AsthmaAsthmaMediatingCytokineAirway HyperresponsivenessInflammatory ResponseInterleukin-13InflammationInfiltrationInflammatoryInterleukin-17Allergic InflammationEpithelial CellsImmunoglobulin AEnvironmental Health
Grant awards (4)
Impact of in utero smoke exposure on NK cells and allergic lung inflammation$431,163
R15 · FY2018 · HL · contact PI
CB2 agonists as novel therapeutic agents that limit allergic lung inflammation$409,954
R15 · FY2012 · HL · contact PI
ROLE OF INNATE IMMUNITY IN OZONE-INDUCED ASTHMA EXACERBATIONS$163,794
P20 · FY2011 · RR · contact PI
ROLE OF TH17 CELLS IN LUNG INFLAMMATION: MODULATION BY OZONE AND ENVIRONMENTAL T$11,811
P20 · FY2009 · RR · contact PI